Editas Medicine earnings

Next report

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 10, 2025 and Nov 4, 2024, after the close.

Who else reports that week: the earnings calendar.

Last report: Aug 5, 2026, 16:03 ET (after the close). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 3.74% either way. Up 4 of 4.

Moves are only shown for reports where we hold closing prices.

1. Aug 5, 202616:03 ET · after the close8-K ↗+5.45%1DRevenue $11.89M+232.3% y/yEPS −$0.15quarter to Jun 30, 2026
2. May 5, 202607:03 ET · before the open8-K ↗+1.33%1DRevenue $2.83M−39.2% y/yEPS −$0.26quarter to Mar 31, 2026
3. Mar 9, 202607:02 ET · before the open8-K ↗+16.00%1DRevenue $24.74M−19.2% y/yquarter to Dec 31, 2025
4. Nov 10, 202507:06 ET · before the open8-K ↗+2.02%1DRevenue $7.54M+12265.6% y/yEPS −$0.28quarter to Sep 30, 2025
5. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
6. Aug 12, 202516:03 ET · after the close8-K ↗Revenue $3.58M+597.5% y/yEPS −$0.63quarter to Jun 30, 2025
7. May 12, 202516:32 ET · after the close8-K ↗Revenue $4.66M+310.4% y/yEPS −$0.92quarter to Mar 31, 2025
8. Mar 5, 202516:11 ET · after the close8-K ↗Revenue $30.60M−49.0% y/yquarter to Dec 31, 2024
9. Jan 13, 202509:03 ET · before the open8-K ↗Revenue $30.60M−49.0% y/yquarter to Dec 31, 2024
10. Nov 4, 202407:33 ET · before the open8-K ↗Revenue $61.00K−98.9% y/yEPS −$0.75quarter to Sep 30, 2024
11. Aug 7, 202407:06 ET · before the open8-K ↗Revenue $513.0K−82.2% y/yEPS −$0.82quarter to Jun 30, 2024
12. May 8, 202407:08 ET · before the open8-K ↗Revenue $1.14M−88.5% y/yEPS −$0.76quarter to Mar 31, 2024
13. Feb 28, 202407:06 ET · before the open8-K ↗Revenue $60.05M+818.7% y/yquarter to Dec 31, 2023
14. Nov 3, 202307:06 ET · before the open8-K ↗Revenue $5.34M+12604.8% y/yEPS −$0.55quarter to Sep 30, 2023
15. Aug 2, 202307:16 ET · before the open8-K ↗Revenue $2.89M−54.6% y/yEPS −$0.56quarter to Jun 30, 2023
16. May 5, 202307:16 ET · before the open8-K ↗Revenue $9.85M+45.5% y/yEPS −$0.71quarter to Mar 31, 2023

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 1 other Item 2.02 filing, filed weeks ahead of a report (a delivery or preliminary update), is not counted as a report. Prior-session closes only; not a forecast, not advice.